InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: abeta post# 323478

Wednesday, 10/28/2020 8:14:06 AM

Wednesday, October 28, 2020 8:14:06 AM

Post# of 687626
The trial didn´t stop because for superior efficacy because of the unexpected high number of patients crossing over from placebo to dcvax-l. And because the primary endpoint was PFS, it was too hard to determine PFS/pseudo PFS. that´s the only reason.
So only the bullish case remains. Do your dd.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News